PEP-Therapy
Developer of innovative peptides designed to offer targeted therapies for severe diseases, with an initial focus on oncology. The company's peptides are active compounds that penetrate cells and block relevant intracellular protein interactions that offer intracellular delivery of targeted therapies.
1
Funding Rounds
$3.1m
Money raised
Overview
Developer of innovative peptides designed to offer targeted therapies for severe diseases, with an initial focus on oncology. The company's peptides are active compounds that penetrate cells and block relevant intracellular protein interactions that offer intracellular delivery of targeted therapies.
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| An***** Pr***** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| An***** Pr***** | - | - | - |
Funding series
Funding Series Analysis
The company PEP-Therapy has raised a total of $3.1m in funding over 1 rounds.
Key Insights:
- PEP-Therapy Series A round, July 2021: $3.1m
PEP-Therapy Series A round, July 2021
$3.1m
Industries
PEP-Therapy is active in the following industries: